Amgen Italia company information, Employees & Contact Information

Will FDA Approval of TEZSPIRE for CRSwNP Expand Amgen's (AMGN) Treatment Portfolio and Market Reach? simplywall.st

Amgen expands restructuring plan to include up to 1100 further job losses FirstWord Pharma

Amgen Gears Up to Report Q2 Earnings: Will the Beat Streak Continue? TradingView

Amgen: Imdelltra Could Be The Next Game Changer (NASDAQ:AMGN) Seeking Alpha

Amgen at TD Cowen Conference: Strategic Growth and Future Prospects Investing.com

Championing Quality Every Day Amgen

Diversity matters at Amgen Providence Business News

Which companies are endorsing remote, hybrid work? HRD America

Securities Tax Disclosure Suit Against Amgen Survives Dismissal Tax Notes

Volastra licenses Amgen molecule for chromosomally unstable cancers Chemical & Engineering News

At Amgen, It’s 'Innovate or Die' Says Amgen CEO Bob Bradway in Interview with Morgan Stanley Amgen

Sanofi and Regeneron File Respondents' Brief on Amgen v. Sanofi JD Supra

Induced protein proximity drug discovery, from 30,000 feet Nature

Investing in Amgen (NASDAQ:AMGN) five years ago would have delivered you a 47% gain Yahoo Finance

Amgen Lowers Cholesterol-Medication Price After Trump Call for Price Cuts - WSJ The Wall Street Journal

Big Data and AI Give Patients with Genetic Cholesterol Disorder a Head Start on Better Health Amgen

Amgen Breaks Ground on New Drug Substance Manufacturing Facility in North Carolina Amgen

How Amgen Is Working to Close the Care Gap This World Cancer Day Amgen

He Died of Cancer, but Fought Until the End: ‘I Did Not Live with an Ill Man’ Amgen

Amgen Origins: The Single Arm that Relieved Many Backs Amgen

UCLA Anderson MBAs Bring Business Acumen to Amgen UCLA Anderson School of Management

SINGZYME WINS 2025 AMGEN X NSG GOLDEN TICKET FOR BREAKTHROUGH BIOCONJUGATION PLATFORM Yahoo Finance

Amgen's Lumakras flunks FDA expert meeting, but market withdrawal looks unlikely for now Fierce Pharma

Investing in Amgen (NASDAQ:AMGN) three years ago would have delivered you a 35% gain Yahoo Finance

Exclusive: Horizon CEO Tim Walbert talks M&A, FTC post-Amgen deal close Endpoints News

The Bull Case For Amgen (AMGN) Could Change Following Phase 3 Rocatinlimab Data Release Yahoo Finance

Amgen Breaks Ground on NC Biomanufacturing Facility Genetic Engineering and Biotechnology News

Prime time for Five Prime as Amgen snaps up this once-moribund biotech for $1.9B and its phoenix-from-the-flames cancer asset Fierce Biotech

Amgen Is Getting Into the Obesity Drug Business. The Stock Could Become the Next Winner. Barron's

Amgen exits neuroscience R&D as pharma pulls back from field BioPharma Dive

Amgen's (NASDAQ:AMGN) three-year earnings growth trails the 10% YoY shareholder returns Yahoo Finance

Amgen must face lawsuit claiming it hid $10.7 billion tax bill Reuters

Mass exodus of Amgen sales reps sparks legal battle with multiple myeloma rival Karyopharm Fierce Pharma

Amgen at Wells Fargo Conference: Strategic Growth and Innovation Investing.com

Amgen sponsors the QB3@953 life sciences incubator Drug Target Review

ASCO: Amgen deals 'knockdown punch' with Lumakras approval, but decades of work lie ahead Fierce Biotech

How scientists shot down cancer’s ‘Death Star’ University of California, Berkeley

URI launches on-line biotechnology class – Rhody Today The University of Rhode Island

Former RayzeBio CEO quickly returns with new biotech; Amgen’s global research leader steps down Endpoints News

Bristol Myers Squibb buys Mirati for up to $5.8B as I-O giant branches out into targeted therapy for cancer Fierce Pharma

Relief for Amgen as it wins Otezla patent appeal pharmaphorum

Amgen wants in on the booming weight loss drug market — and it's taking a different approach CNBC

Amgen boots up Ohio 'smart facility' where it plans to employ 400—and a trio of robots, too Fierce Pharma

Enbrel Battle Ends as Supreme Court Refuses to Hear Sandoz Appeal BioSpace

Bushu expects to double the volume of Amgen drugs it makes under new Asia CMO pact Fierce Pharma

Amgen, Ideaya Call It Quits on Cancer Combo BioSpace

Amgen at RBC Capital Markets: Strong Start and Strategic Focus Investing.com

Amgen Stock: Bet On Its Breakthrough Drug (NASDAQ:AMGN) Seeking Alpha

Joe and Jennifer Montana team up to quarterback Amgen’s new heart disease awareness campaign Fierce Pharma

Amgen takes on AbbVie’s blockbuster Humira with unusual price plan Crain's Chicago Business

Developer buys Amgen property for $25M Thousand Oaks Acorn

Sandoz head: Enbrel biosimilar Erelzi won't launch before 2018, delayed by legal battle Fierce Pharma

How Scientists Shot Down Cancer’s ‘Death Star’ (Published 2021) The New York Times

Brain Wave: Neumora Aims Precision Medicine at Neuro Diseases with $500M Launch, Amgen Alliance Genetic Engineering and Biotechnology News

Amgen: The Buying Opportunity Has Now Arrived (Rating Upgrade) Seeking Alpha

FDA approves a third biosimilar, with the largest market Fierce Biotech

Amgen swallows Onyx whole Nature

Amgen Slashes the Price of a Promising Cholesterol Drug (Published 2018) The New York Times

University’s Welsh-language ambitions shared at Eisteddfod AmGen 2021 Cardiff University

The margin of safety: the ten-billion-dollar lesson from Amgen The Economic Times

First Biosimilar Drug Inches Closer to Entering U.S. Market The Regulatory Review

Anaemic outlook for Amgen Nature

Amgen To Acquire Onyx, Maker Of Kyprolis; What Does It Mean For The Myeloma Community? The Myeloma Beacon

Venture Capital Pioneer Illuminates the Silicon Valley Ecosystem Stanford Graduate School of Business